Okada F, Hosokawa M, Hasegawa J, Kuramitsu Y, Nakai K, Yuan L, Lao H, Kobayashi H, Takeichi N
Laboratory of Cell Biology, Hokkaido University School of Medicine, Sapporo, Japan.
Br J Cancer. 1994 Aug;70(2):233-8. doi: 10.1038/bjc.1994.285.
We have previously reported that an increase in the production of immunosuppressive prostaglandin E2 by a QR tumour (QR-32) is accompanied by progressive growth of the tumour in syngeneic C57BL/6 mice. In order to determine what kinds of cell and factor(s) enable QR-32 cells to promote PGE2 production, we investigated the amounts of PGE2 in the supernatant of QR-32 cells by co-culturing them with various anti-tumour effector cells. Significantly high levels of PGE2 production were observed when the QR-32 cells were co-cultured with lymphokine-activated killer (LAK) cells, natural killer (NK) cells, polymorphonuclear (PMN) leucocytes and streptococcal preparation (OK432)-activated or resident peritoneal macrophages (activated and resident macrophages). On the other hand, PGE2 production was not increased when QR-32 cells were co-cultured with cytotoxic T lymphocytes (CTLs) specific to QR-32 cells. The high levels of PGE2 production were partially or totally inhibited by the presence of radical scavengers such as superoxide dismutase (SOD), catalase and mannitol, although the cytotoxicity of LAK cells was not. We also exposed QR-32 cells to human recombinant cytokines and the growth factors which are produced when anti-tumour effector cells come in contact with tumour cells. Significant PGE2 production by QR-32 cells was observed when the cells were treated with interferon alpha (IFN-alpha), tumour necrosis factor alpha (TNF-alpha) and transforming growth factor beta (TGF-beta) (all P < 0.001). These results suggest that oxygen radicals produced by anti-tumour effector cells and inflammatory cytokines provoke QR-32 cells to produce large amounts of immunosuppressive PGE2.
我们之前报道过,QR肿瘤(QR-32)产生的免疫抑制性前列腺素E2增加,同时同基因C57BL/6小鼠体内的肿瘤会逐渐生长。为了确定何种细胞和因子能使QR-32细胞促进前列腺素E2的产生,我们通过将QR-32细胞与各种抗肿瘤效应细胞共培养,研究了QR-32细胞上清液中前列腺素E2的含量。当QR-32细胞与淋巴因子激活的杀伤细胞(LAK细胞)、自然杀伤细胞(NK细胞)、多形核(PMN)白细胞以及经链球菌制剂(OK432)激活的或驻留的腹腔巨噬细胞(激活的和驻留的巨噬细胞)共培养时,观察到显著高水平的前列腺素E2产生。另一方面,当QR-32细胞与针对QR-32细胞的细胞毒性T淋巴细胞(CTL)共培养时,前列腺素E2的产生并未增加。尽管LAK细胞的细胞毒性不受影响,但自由基清除剂如超氧化物歧化酶(SOD)、过氧化氢酶和甘露醇的存在会部分或完全抑制高水平的前列腺素E2产生。我们还将QR-32细胞暴露于重组人细胞因子以及抗肿瘤效应细胞与肿瘤细胞接触时产生的生长因子中。当用α干扰素(IFN-α)、肿瘤坏死因子α(TNF-α)和转化生长因子β(TGF-β)处理细胞时,观察到QR-32细胞产生显著的前列腺素E2(所有P<0.001)。这些结果表明,抗肿瘤效应细胞产生的氧自由基和炎性细胞因子促使QR-32细胞产生大量免疫抑制性前列腺素E2。